Intellipharmaceutics International, Inc.
(Toronto Stock Exchange : IPCI)

( )
IPCI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
VTLVital Therapies, Inc.
1.50%13.513.3%$792.68m
AMGNAmgen Inc.
0.97%206.001.3%$773.44m
GILDGilead Sciences, Inc.
1.54%64.110.9%$388.34m
CELGCelgene Corporation
0.51%95.221.3%$348.72m
BIIBBiogen Inc.
1.74%235.721.3%$309.32m
ILMNIllumina, Inc.
0.87%288.653.5%$303.84m
VRTXVertex Pharmaceuticals Incorporated
1.16%187.091.9%$267.03m
ALXNAlexion Pharmaceuticals, Inc.
1.65%112.682.0%$250.97m
EXASExact Sciences Corporation
-1.39%118.1624.1%$248.01m
REGNRegeneron Pharmaceuticals, Inc.
0.52%298.382.6%$217.05m
AAgilent Technologies, Inc.
0.96%71.761.6%$206.55m
SRPTSarepta Therapeutics, Inc.
-3.71%120.3114.7%$153.85m
INCYIncyte Corporation
1.68%84.522.5%$100.26m
BMRNBioMarin Pharmaceutical Inc.
1.19%77.414.3%$94.71m
GHDXGenomic Health, Inc.
-0.56%74.221.8%$90.42m

Company Profile

Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.